Impact of COVID-19 in public health: Prevalence and preventive approaches.
Pak J Pharm Sci
; 33(4): 1739-1745, 2020 Jul.
Article
in English
| MEDLINE | ID: covidwho-1080067
ABSTRACT
The outbreak of CoVID-19 infection rapidly increases worldwide. Most of the continents affecting from CoVID-19 and still widening its burden disease (Jones DS, 2020; Lai et al., 2020). Along with its fatality rates, CoVID-19 has caused physiological disturbances in the society and termed as "coronophobia". CoVID-19 with renal failure, severe pneumonia and respiratory syndrome patients have been reported to increase the severity of disease conditions (Sevim et al., 2020). Also, CoVID-19 with cancer patients increase the higher risk of infections. Currently, there is no vaccine or specific treatment against CoVID-19 and drug research centres continuously investigating the potential drug against CoVID-19 (Osama and Amer, 2020). For the past 20 years two major coronavirus epidemics have occurred in public includes SARS-CoV approximately 8000 cases and 800 deaths and MERS-CoV 2,500 cases and 800 deaths and these continuing sporadically (Cascella et al., 2020).
Search on Google
Collection:
International databases
Database:
MEDLINE
Main subject:
Communicable Disease Control
/
COVID-19
Type of study:
Experimental Studies
/
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Pak J Pharm Sci
Journal subject:
Pharmacy
/
Pharmacology
/
Chemistry
Year:
2020
Document Type:
Article
Affiliation country:
Malaysia
Similar
MEDLINE
...
LILACS
LIS